Epigenetic mechanisms of promigratory chemokine CXCL14 regulation in human prostate cancer cells.
Chemokines play the key role in initiating immune responses by regulating the attraction and homing of immune cells to the lymphoid and nonlymphoid tissues. CXCL14 is a chemokine that in tumors may act as chemoattractant for monocytes and dendritic cells (DC), which may modulate antitumor immune responses in certain cancers. In this study, we investigated the mechanisms of loss of CXCL14 in prostate cancer cells. Cell treatment with the demethylating agent 5-aza-2-deoxycytidine resulted in the recovery of CXCL14 mRNA and protein expression. Hypermethylated CpG island sequences encompassing the CXCL14 gene promoter were identified. The restoration of CXCL14 by 5-aza-2-deoxycytidine treatment had functional impact, based on the DC chemoattractant activity of conditioned medium from drug-treated cells. Conversely, CXCL14 removal from conditioned media by affinity chromatography abolished its chemotactic properties, confirming that functionally active CXCL14 was generated in prostate cancer cells by relieving its transcriptional silencing with 5-aza-2-deoxycytidine. Our findings offer the first direct evidence for epigenetic regulation of chemokine expression in tumor cells.
Song
Eun Young
EY
Seoul National University College of Medicine, Seoul, South Korea.
Shurin
Michael R
MR
Tourkova
Irina L
IL
Gutkin
Dmitriy W
DW
Shurin
Galina V
GV
D000230:Adenocarcinoma / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D001483:Base Sequence; D045744:Cell Line, Tumor; D002465:Cell Movement / Q000502:physiology; D019743:Chemokines, CXC / Q000096:biosynthesis / Q000235:genetics*; D019175:DNA Methylation / Q000187:drug effects; D000077209:Decitabine; D015536:Down-Regulation; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D011401:Promoter Regions, Genetic; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D012333:RNA, Messenger / Q000096:biosynthesis / Q000235:genetics
C118056:CXCL14 protein, human; D019743:Chemokines, CXC; D012333:RNA, Messenger; D000077209:Decitabine; D001374:Azacitidine
Mol Cancer Ther. 2001 Nov;1(1):61-7
12467239
Clin Cancer Res. 1998 Mar;4(3):585-93
9533525
Methods Mol Biol. 2003;215:437-62
12512319
Trends Genet. 2000 Apr;16(4):168-74
10729832
Exp Hematol. 2006 Aug;34(8):1101-5
16863917
Oncol Rep. 2003 Sep-Oct;10(5):1237-40
12883687
J Immunol. 2000 Sep 1;165(5):2588-95
10946286
Cancer Res. 2004 Nov 15;64(22):8262-70
15548693
Cancer Res. 2002 Jun 15;62(12):3498-502
12067994
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):710-5
10639144
J Biol Chem. 2002 Apr 26;277(17):14877-83
11836256
Annu Rev Genomics Hum Genet. 2002;3:101-28
12142355
Prostate. 2005 Jun 15;64(1):67-74
15651028
Cancer. 2000 Dec 15;89(12):2646-54
11135227
Cytokine. 2008 Nov;44(2):248-55
18809336
Cancer Res. 2001 Dec 15;61(24):8659-63
11751381
J Pathol. 2007 May;212(1):83-90
17334979
J Immunol. 2000 Mar 15;164(6):3200-6
10706711
J Exp Med. 2001 Sep 17;194(6):855-61
11561000
Immunol Cell Biol. 2002 Oct;80(5):489-96
12225386
Cancer Res. 1995 Nov 15;55(22):5195-9
7585573
Int J Cancer. 2003 Mar 10;104(1):92-7
12532424
J Clin Invest. 2000 May;105(10):1383-93
10811846
Semin Cancer Biol. 2002 Oct;12(5):331-7
12191632
Annu Rev Immunol. 2000;18:767-811
10837075
J Mol Biol. 2006 Nov 3;363(4):813-22
16987528
Nat Immunol. 2001 Feb;2(2):123-8
11175804
Cancer Res. 2004 Feb 1;64(3):969-76
14871827
J Pathol. 2008 Nov;216(3):295-306
18788075
J Immunol. 2005 May 1;174(9):5490-8
15843547
Biochem Biophys Res Commun. 1999 Feb 24;255(3):703-6
10049774
Cancer Detect Prev. 2007;31(5):359-65
18037591
Am J Pathol. 2000 Jun;156(6):1937-50
10854217
J Natl Cancer Inst. 2003 Mar 5;95(5):399-409
12618505
Int J Cancer. 2001 Oct 15;94(2):243-51
11668505
Immunity. 2005 Sep;23(3):331-42
16169505
J Invest Dermatol. 2002 Jun;118(6):915-22
12060384
Clin Cancer Res. 2007 Feb 1;13(3):832-8
17289874
Cancer Res. 2001 Dec 15;61(24):8611-6
11751372
Cancer Res. 2001 Jan 1;61(1):249-55
11196170